Figure 5

Quantification of azido-functionalized sphingolipid levels in membrane fractions of N. meningitidis by mass spectrometry. Characterization of membrane fractions (1–12) of N. meningitidis after treatment of bacteria with either ω-N3-sphingosine (a) or ω-N3-C6-ceramide (b). Each fraction was tested for LDH activity per µg protein (blue line), as inner membrane marker and OpcA abundance by dot blot (below X-axis) as outer membrane marker. Bars represent the amount of azido-functionalized sphingosine or ceramide, as determined by HPLC–MS/MS, normalized to the amount of C16 sphingomyelin (SM) found in the samples. LDH data show the mean ± SD of a representative experiment performed in duplicate.